Blood-based biomarkers (BBM) for Alzheimer disease (AD) improve accuracy of diagnosis, according to a study presented at the annual Alzheimer’s Association In ...

The AHA released a scientific statement on tailored exercise training for patients with high-risk cardiovascular conditions.

The American Heart Association issued a scientific statement on deprescribing for patients with cardiovascular disease and polypharmacy.

Kalshi and AppliedXL launch a pilot prediction market for late-stage clinical trial outcomes and FDA decisions using objective public data sources.

Finerenone plus empagliflozin combination therapy reduces systolic blood pressure in patients with T2D and chronic kidney disease.

A cohort study indicates prepregnancy BMI and race, ethnicity interact to influence the prevalence and risk for preeclampsia, eclampsia.

Postmenopausal women with a history of migraine may have an increased risk for ischemic stroke, according to recent study findings.

Hypoactive sexual desire disorder is a common, underrecognized condition in women that arises from neurologic, hormonal, and psychosocial factors. Cardiology Advisor, a trusted source of medical news ...

Patients with continuous public insurance or frequent coverage changes face higher mortality and graft failure risk after heart transplantation.

Center volume for fetal aortic valvuloplasty is not associated with technical success or complications but is linked to lower periprocedural death.

The FDA has granted Fast Track designation to invobenitug, an investigational anti-cDPP3 monoclonal antibody designed to restore RAAS balance in cardiogenic shock.